Anti-benzylpenicilloyl immunoglobulin E (BPO-IgE)

Anti-benzylpenicilloyl immunoglobulin E (BPO-IgE) is a specific antibody isotype that mediates Type I hypersensitivity reactions to penicillin G and its derivatives. It recognizes the benzylpenicilloyl moiety, which is the major antigenic determinant formed when the beta-lactam ring of penicillin opens and covalently binds to host proteins (NIH StatPearls). In sensitized individuals, BPO-IgE molecules are typically bound to high-affinity FcεRI receptors on the surface of mast cells and basophils. Subsequent exposure to penicillin causes the multivalent BPO-hapten-protein complexes to cross-link these antibodies, triggering the explosive release of inflammatory mediators such as histamine, leukotrienes, and cytokines (World Allergy Organization Journal). This biological cascade is the underlying mechanism for penicillin-induced urticaria and life-threatening anaphylaxis. While BPO-IgE is a critical diagnostic biomarker used in skin testing and in vitro assays to confirm penicillin allergy, it is also a therapeutic target for monoclonal antibodies like omalizumab, which neutralize circulating IgE to prevent allergic effector cell activation (FDA Label). Furthermore, BPO-IgE levels and activity are central to rapid desensitization protocols, where controlled, incremental dosing aims to temporarily deplete or internalize these antibodies to allow the safe administration of necessary beta-lactam antibiotics (Journal of Allergy and Clinical Immunology).

Other names

Benzylpenicilloyl-specific IgEPenicillin G-specific IgEAnti-BPO IgEMajor determinant-specific IgE

Therapeutic monoclonal antibodies like omalizumab bind to the Cε3 domain of the IgE Fc region, which overlaps with the binding site for the high-affinity FcεRI receptor, thereby sequestering circulating BPO-IgE and preventing it from docking on mast cells and basophils (PubChem, FDA). Diagnostic agents like benzylpenicilloyl polylysine act as multivalent haptens that cross-link the BPO-IgE already present on sensitized mast cells to elicit a controlled local allergic response during skin testing (StatPearls).